Tim Cernohous of Cencora explains why patient trust no longer guarantees satisfaction—and how automation and better communication can close the gap with mail order.
|Articles|July 25, 2022
Daily OTC Pearl: Alocane
Author(s)Saro Arakelians, PharmD
Alocane provides fast pain relief and helps the healing process from minor burns.
Advertisement
OTC/Lifestyle Pearl of the Day: Alocane
Indication: Alocane provides fast pain relief and helps the healing process from minor burns.
Insight:
- Active ingredient: 1,3-propanediol, aloe barbadensis (aloe) leaf juice, dimethyl isosorbide, hydroxyethyl cellulose, phenoxyethanol, chlorphenesin, caprylyl glycol, tocopheryl acetate (vitamin E), water.
- Directions: For adults and children 2 years of age or older, apply to affected area not more than 3 to 4 times daily. Children under 2 years of age, consult a physician. Do not use in large quantities, particularly over raw surfaces or blistered areas.
- Warning: Avoid eye contact
Source:
Advertisement
Related to this article
Eight Humira biosimilars have been launched, but payer formularies and interchangeability rules decide what dispenses.
At NEIAP 2026, Kelsey Norman, PharmD, walked through how VESALIUS-CV, Lp(a)HORIZON, and CKM guidelines change pharmacist-led lipid care.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
The data helps pharmaicts predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
CDC-recommended adult vaccination programs for pneumococcal disease, RSV, influenza, and COVID-19 prevent over 182,000 deaths and generate up to $12 in societal value for every $1 spent.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Data Reshapes Nonstatin Lipid Therapy Choices
2
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
3
Etentamig Reduces Risk of Progression or Death by 60% in Relapsed/Refractory Multiple Myeloma
4
Medication Management: A Crucial Part of Healthy Aging
5